Aggression and central neurotransmitters.
D000110:Acetylcholinesterase / Q000378:metabolism; D000374:Aggression / Q000187:drug effects / Q000502:physiology*; D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000502:physiology*; D002217:Carbachol / Q000494:pharmacology; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004296:Dopa Decarboxylase / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000378:metabolism* / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D006892:Hydroxydopamines; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D010276:Parasympatholytics; D010868:Pimozide; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D002217:Carbachol; D000547:Amantadine; D004299:Dopamine beta-Hydroxylase; D008995:Monoamine Oxidase; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase; D004296:Dopa Decarboxylase; D001058:Apomorphine; D014403:Tubocurarine